Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Research
Molecular Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Highlights

Highlights of This Issue

DOI:  Published March 2019
  • Article
  • Info & Metrics
  • PDF
Loading

Lipids from Adipocytes Support Prostate Cancer Progression

Laurent et al. Page 821

Adipose tissue induces a pro-tumorigenic effect and promotes cancer aggressiveness. Here, Laurent and colleagues demonstrate that periprostatic adipose tissue (PPAT) engages in bidirectional interactions with prostate cancer cells, which are up-regulated by obesity. Prostate cancer cells induced lipolysis in adipocytes, thereby releasing free fatty acids (FFAs) into the microenvironment. FFA uptake by prostate cancer cells increased both expression of the NADPH oxidase NOX5 and intracellular levels of reactive oxygen species (ROS). This in turn led to increased activity of the HIF1/MMP14 pathway and tumor invasion. Analysis of prostate tumor sections revealed that cells at the invasive front harbor increased NOX5 and MMP14 expression when adjacent to PPAT, thus underscoring the importance of these observations.

ALK Fusions in LMS

Davis et al. Page 676

Leiomyosarcoma is an aggressive soft tissue tumor that responds poorly to systemic chemotherapy, and for which no targeted molecular therapies are currently available. Here, Davis and colleagues describe the first functional validation of recurrent gene fusions with ALK kinase, a targetable oncogene with therapeutic potential. Cells bearing these fusions were shown to be highly sensitive to kinase inhibitors such as lorlatinib. These findings suggest that clinical cases of sarcoma, particularly leiomyosarcoma, could harbor undiscovered driver gene fusions that may significantly improve clinical outcomes.

NF-κB and PARP1 Form a Loop Regulating DNA Repair

Li et al. Page 761

DNA-damaging chemotherapy is a standard intervention for acute myeloid leukemia (AML), but acquired resistance to these therapies via activation of NF-κB is a major clinical hurdle. Here, Li and colleagues demonstrate that the NF-κB subunit RELA directly binds and regulates PARP1, a key mediator of the DNA damage response. Further, ablation of PARP1 was shown to inhibit NF-κB activity, and co-targeting of NF-κB and PARP1 with small molecules yielded robust responses in vivo. Taken together, this study sets forth a rationale for new clinical approaches to managing resistance to chemotherapy in AML.

Fusion and Stemness of Prostate Cancer Cells

Uygur et al. Page 806

Interactions between malignant and non-malignant cells in the tumor microenvironment have a significant bearing on the development, progression, and aggressiveness of cancer. In this study, Uygur and colleagues describe a novel interaction between prostate cancer cells and the normal muscle cells that surround the prostate gland. Contact between prostate cancer and muscle cells had pronounced effects on tumor cell biology, including upregulation of anti-inflammatory interleukins and subsequent expression of syncytin 1 and annexin A5, proteins involved in cancer cell fusion. Expression of these factors was shown to correlate with tumor stage, suggesting that tumor-muscle cell interactions may promote disease progression in clinical prostate cancer.

  • ©2019 American Association for Cancer Research.
PreviousNext
Back to top
Molecular Cancer Research: 17 (3)
March 2019
Volume 17, Issue 3
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Highlights of This Issue
(Your Name) has forwarded a page to you from Molecular Cancer Research
(Your Name) thought you would be interested in this article in Molecular Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Highlights of This Issue
Mol Cancer Res March 1 2019 (17) (3) 667;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Highlights of This Issue
Mol Cancer Res March 1 2019 (17) (3) 667;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Lipids from Adipocytes Support Prostate Cancer Progression
    • ALK Fusions in LMS
    • NF-κB and PARP1 Form a Loop Regulating DNA Repair
    • Fusion and Stemness of Prostate Cancer Cells
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Selected Articles from This Issue
  • Selected Articles from This Issue
  • Selected Articles from This Issue
Show more Highlights
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Rapid Impact Archive
  • Meeting Abstracts

Information for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCR

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Research
eISSN: 1557-3125
ISSN: 1541-7786

Advertisement